Selected article for: "cell growth and tumor growth"
Author: Lim, Jun Hyeok; Ryu, Jeong-Seon; Cho, Sang Yong; Kim, Hyun-Jung; Jeon, Sang Hoon; Kim, Jung Soo; Nam, Hae-Seong; Cho, Jae Hwa; Kwak, Seung Min; Lee, Hong Lyeol
Title: Small-cell Lung Cancer Presenting as Fatal Pulmonary Hemorrhage
  • Document date: 2018_3_21
    • ID: r69j2tnw_1
    Snippet: Small-cell lung cancer (SCLC) represents 15-20% of all lung cancers [1] . SCLC differs from non-small-cell lung cancer in its rapid tumor doubling time, high growth fraction, early development of widespread metastasis, and better response to platinum doublets chemotherapy. Thus chemotherapy is a treatment mainstay, even in poor Eastern Cooperative Oncology Group (ECOG) performance status [2, 3] . Bone marrow involvement or paraneoplastic syndrome.....
    Document: Small-cell lung cancer (SCLC) represents 15-20% of all lung cancers [1] . SCLC differs from non-small-cell lung cancer in its rapid tumor doubling time, high growth fraction, early development of widespread metastasis, and better response to platinum doublets chemotherapy. Thus chemotherapy is a treatment mainstay, even in poor Eastern Cooperative Oncology Group (ECOG) performance status [2, 3] . Bone marrow involvement or paraneoplastic syndrome is common in patients with SCLC [4] . Hematologic abnormalities such as anemia, leukopenia, and thrombocytopenia are reported to be occasionally accompanied by bone marrow metastasis or paraneoplastic phenomenon [5, 6] . However, complications such as fatal hemorrhage are rarely reported. The clinical presentation can make diagnosis or treatment difficult. Herein, we report an SCLC patient who presented with rapid-onset, refractory severe thrombocytopenia and development of fatal pulmonary hemorrhage.

    Search related documents:
    Co phrase search for related documents
    • bone marrow involvement and marrow involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • bone marrow metastasis and clinical presentation: 1
    • bone marrow metastasis and marrow metastasis: 1, 2
    • bone marrow metastasis and paraneoplastic phenomenon: 1
    • bone marrow metastasis and paraneoplastic phenomenon bone marrow metastasis: 1
    • clinical presentation and early development: 1
    • clinical presentation and ECOG performance: 1
    • clinical presentation and ECOG performance status: 1
    • clinical presentation and fatal hemorrhage: 1
    • clinical presentation and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • clinical presentation and marrow involvement: 1
    • clinical presentation and marrow metastasis: 1
    • clinical presentation and non small cell: 1, 2, 3, 4, 5
    • clinical presentation and non small cell lung cancer: 1, 2, 3, 4
    • clinical presentation and paraneoplastic syndrome: 1
    • clinical presentation and pulmonary hemorrhage: 1, 2, 3, 4
    • clinical presentation and rapid onset: 1, 2, 3, 4
    • clinical presentation and SCLC small cell lung cancer: 1
    • clinical presentation and small cell: 1, 2, 3, 4, 5, 6, 7, 8